Reversible Posterior Leukoencephalopathy Syndrome Induced by RAF Kinase Inhibitor BAY 43-9006
Author:
Affiliation:
1. University of Arkansas for Medical Sciences, Little Rock, AR
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.08.4608
Reference6 articles.
1. A Reversible Posterior Leukoencephalopathy Syndrome
2. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed
3. Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
4. Oczan C: Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 354:981,2006,
5. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neuro-ophthalmic complications of modern anti-cancer drugs;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-12
2. Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review;Frontiers in Pharmacology;2023-12-15
3. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma;Brain Sciences;2022-12-23
4. Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients;International Immunopharmacology;2021-12
5. Neurologic Complications;Abeloff's Clinical Oncology;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3